The Istituto Giannina Gaslini is the biggest pediatric hospital of North Italy, located in Genoa Quarto dei Mille and founded by the Italian industrialist, politician and phylanthropist Gerolamo Gaslini in 1938.

There are 516 beds in Istituto Giannina Gaslini.

During the past decade, Istituto Giannina Gaslini conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 12 clinical trials were completed, i.e. on average, 17.4% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 11 clinical trials were completed. i.e. 29.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Istituto Giannina Gaslini" #1 sponsor was "Istituto Giannina Gaslini" with 8 trials, followed by "Vertex Pharmaceuticals Incorporated" with 7 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Italian Sarcoma Group" with 6 trials sponsored and "European Infant Neuroblastoma Study Group - 1999" with 6 trials sponsored. Other sponsors include 64 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Giannina Gaslini" #1 collaborator was "Istituto Giannina Gaslini" with 4 trials as a collaborator, "Associazione Italiana Ematologia Oncologia Pediatrica" with 2 trials as a collaborator, "Azienda Policlinico Umberto I" with 2 trials as a collaborator, "Bambino Gesù Hospital and Research Institute" with 2 trials as a collaborator and "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Giannina Gaslini" are "Neuroblastoma" (10 trials), "Cystic Fibrosis" (9 trials), "Juvenile Idiopathic Arthritis" (3 trials), "Nephrotic Syndrome" (3 trials) and "Anaesthesia" (2 trials). Many other conditions were trialed in "Istituto Giannina Gaslini" in a lesser frequency.

Most popular intervention types in "Istituto Giannina Gaslini" are "Drug" (67 trials), "Other" (8 trials), "Procedure" (6 trials), "Biological" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "IVA" (7 trials), "Cyclophosphamide" (5 trials), "ELX/TEZ/IVA" (5 trials) and "Ifosfamide" (5 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Giannina Gaslini" are 96 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Istituto Giannina Gaslini". undefined are not yet recruiting, 24 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 44 completed trials in Istituto Giannina Gaslini, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Giannina Gaslini, 12 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

Istituto Giannina Gaslini has several departments that took part in Clinical trials: "IRCCS Istituto Giannina Gaslini; U.O.S.D. Centro di Miologia e Patologie Neurodegenerative" - 3 trials, "Istituto Pediatrico Giannina Gaslini Dipartimento di Neurologia" - 2 trials